This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
This federal contract award, valued at $21,119.70, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to Government Scientific Source Inc., a for-profit organization that specializes in providing laboratory products and equipment to federal agencies. The purpose of this contract is to supply reagents for sequencing to support ongoing clinical research at NHLBI to understand rare and...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to Global Life Sciences Solutions USA LLC. The $517,728.16 firm fixed-price purchase order is for the delivery of scientific equipment, biological materials, and associated services to support the agency's biomedical research programs. This award is part of a larger $1.176 billion cooperative agreement with Global Life Sciences...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
This is a $14,988.32 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was set aside for a small business and awarded to Yoon, Justine S., a woman-owned small business. The contract has an ultimate completion date of October 4, 2013 and was awarded on December 18, 2012. The contract's purpose is not specified in the information provided, but the NHLBI is...
This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for "OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS" under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside designation and was awarded on August 27, 2012, with a completion date of February 26, 2013.